文献速递肿瘤 PET/CT

儿童肿瘤FDG-PET/CT应测量什么及如何测量?常用SUV指标鉴别儿童肿瘤的比较

What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours.
PubMed 文献 · EJNMMI Res · 2019-12-23

该研究纳入61例儿童和青少年(非霍奇金淋巴瘤25例、霍奇金淋巴瘤14例、肉瘤22例),直接比较SUVmax、SUVpeak及分别以肝脏和纵隔血池归一化的SUVratio对常见肿瘤的鉴别能力。结果显示SUVmax、SUVpeak、SUVmax/肝脏和SUVpeak/肝脏均对肿瘤鉴别敏感(p ≤ 0.008),而以纵隔血池归一化的SUVratio不敏感;参考区SUV受体重和摄取时间等因素影响,使用SUVratio时参考区选择至关重要。

要点

  • SUVmax、SUVpeak及以肝脏归一化的SUVratio对儿童常见肿瘤鉴别敏感。
  • 以纵隔血池归一化的SUVmax/纵隔和SUVpeak/纵隔对肿瘤鉴别不敏感。
  • 参考区SUV受体重和摄取时间影响,选择SUVratio时需考虑这些因素。

核心结论

  • 在儿童人群中,不同SUV指标对常见肿瘤的鉴别能力差异明显,使用SUVratio时参考区的选择至关重要。

研究设计与样本

  • 研究纳入61例儿童和青少年,包括非霍奇金淋巴瘤25例、霍奇金淋巴瘤14例和肉瘤22例。
  • 比较的SUV指标包括SUVmax、SUVpeak及分别以肝脏和纵隔血池归一化的SUVmax/肝脏、SUVmax/纵隔、SUVpeak/肝脏和SUVpeak/纵隔。

主要发现

  • SUVmax、SUVpeak、SUVmax/肝脏和SUVpeak/肝脏均对肿瘤鉴别敏感(p ≤ 0.008)。
  • SUVmax/纵隔和SUVpeak/纵隔对肿瘤鉴别不敏感。
  • 相关性分析显示参考区SUV与SUVratio呈负相关(p < 0.05)。
  • 多元回归分析显示体重和摄取时间对参考区SUV有显著影响(p < 0.01),并间接影响相应SUVratio。

关键数值与推荐

  • SUVmax、SUVpeak、SUVmax/肝脏和SUVpeak/肝脏对肿瘤鉴别的p值均≤0.008。
  • 参考区SUV与SUVratio负相关的p值<0.05。
  • 体重和摄取时间对参考区SUV影响的p值<0.01。

临床怎么用

  • 在儿童肿瘤FDG-PET/CT鉴别诊断中,可优先考虑SUVmax、SUVpeak或肝脏归一化的SUVratio。
  • 使用SUVratio时应关注参考区SUV的影响因素(如体重、摄取时间),以避免错误结论。
  • 当无法控制上述影响因素时,SUVmax和SUVpeak是更简单、更稳健的替代指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In clinical routine, SUVmax and SUVpeak are most often used to determine the glucose metabolism in tumours by 18F-FDG PET/CT. Both metrics can be further normalised to SUVs in reference regions resulting in a SUV ratio (SUVratio). The aim of the study was to directly compare several widely used SUVs/SUVratios with regard to differentiation between common tumours in paediatric patients; a special focus was put on characteristics of reference region SUVs. METHODS: The final study population consisted of 61 children and adolescents with diagnoses of non-Hodgkin lymphoma (NHL, n = 25), Hodgkin lymphoma (HL, n = 14), and sarcoma (n = 22). SUV metrics included SUVmax and SUVpeak as well as both parameters normalised to liver and mediastinal blood pool, respectively, yielding the SUVratios SUVmax/liver, SUVmax/mediastinum, SUVpeak/liver, and SUVpeak/mediastinum. RESULTS: The metrics SUVmax, SUVpeak, SUVmax/liver, and SUVpeak/liver all proved to be sensitive for tumour differentiation (p ≤ 0.008); in contrast, SUVmax/mediastinum and SUVpeak/mediastinum revealed to be non-sensitive approaches. Correlation analyses showed inverse associations between reference region SUVs and SUVratios (p < 0.05). Multiple regression analyses demonstrated significant effects of factors as bodyweight and uptake time on reference region SUVs (p < 0.01), and thus indirectly on the corresponding SUVratios. CONCLUSIONS: In the paediatric population, the ability to differentiate between common tumours remarkably varies between SUV metrics. When using SUVratios, the choice of reference region is crucial. Factors potentially influencing reference region SUVs (and thus SUVratios) should be taken into account in order to avoid erroneous conclusions. When not possible, SUVmax and SUVpeak represent less complex, more robust alternatives.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Blautzik J, Grelich L, Schramm N, et al. What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours. EJNMMI Res. 2019. PMID: 31872312. doi:10.1186/s13550-019-0577-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。